NOTT - The University of Nottingham (United Kingdom)
The University of Nottingham hosts a global academic community in campuses in the UK, China and Malaysia. The University was ranked 8th in the UK for research power in the Research Excellence Framework (REF) 2014. Further, over 80% of the research was judged to be ‘world leading’or ‘internationally excellent’.The Faculty of Medicine and Health Sciences within the University of Nottingham, comprises four schools, and undertakes research from basic sciences to clinical translational research. It has 900 postgraduate research students and research income of £170M per annum. The dedicated Clinical Trials Unit and Clinical Research Facility are funded in partnership with Nottingham University Hospitals NHS Trust. The School of Medicine is based on three campuses: Queen’s Medical Centre, the City Hospital and University Park in the new £25 million Centre for Biomolecular Sciences. The School has staff recognized internationally for their research in palliative care and respiratory medicine, along with, e.g. genetics, immunology, haematology, pathology and virology.
Research Excellence Framework (REF) assessments have consistently identified Nottingham as a centre of ‘high research activity’ in relation to palliative care. The Department of Palliative Care sits within the Division of Cancer and Stem cells and has a successful track record of recruiting to commercial and non-commercial trials ranging from in-house to national/international multicentre studies, contributing above and beyond that expected to the UK NCRI Supportive and Palliative Care research portfolio. There is close working with the Nottingham Centre for the Advancement of Research into Supportive, Palliative and End-of-Life Care, that hosts an internationally recognised programme of research, with a particular focus on older people’s needs for palliative and end-of-life care, and the improvement of care in resource poor contexts. Nottingham University is a core collaborating centre of the European Palliative Care Research Centre.
Dr. Andrew Wilcock: Clinical Reader in Palliative Medicine and Medical Oncology